Firefighter Diagnosed with Melanoma Spreads Awareness to Save Lives
…the dermatologist to see about a bleeding mole turned up melanoma, he admits he was knocked off his feet. Seth…
Firefighter Diagnosed with Melanoma Spreads Awareness to Save Lives
…the dermatologist to see about a bleeding mole turned up melanoma, he admits he was knocked off his feet. Seth…
,
Physician Assistant Diagnosed with Melanoma Learns to Make Really Good Lemonade
…discovered and knows it wouldn’t have were it not for melanoma. Now doctors can keep an eye on it. Life…
,
EORTC and Pierre Fabre Partner to Address Treatment Gap for Stage II Melanoma Patients
…skin. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/16-Melanoma-of-skin-fact-sheet.pdf. Accessed June 2021. [4] Klein O, et al. Eur J Cancer 2013;49:1073-1079. [5] Melanoma UK. 2020…
,
,
Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update
…in a prior Phase 2 cohort in the same clinical trial of approximately 30 patients with melanoma. The additional cohorts…
,
,
Ways to Give: Join a Steps Against Melanoma Walk
Steps Against Melanoma is AIM at Melanoma’s Walk & Fun Run program. These Walks are the largest public events AIM…
,
Newly Published Trial Data for Melanoma
…immune cells turn off instead of attacking the growing tumor. When immune cells encounter melanoma cells, they may express a…
,
FAQ and Update on AIM at Melanoma’s International Melanoma Tissue Bank Consortium
…University (Chicago, IL). Finally, the suspected melanoma must be large enough to bank. So ironically, it is people likely unfamiliar…
,
President’s Letter | March 2021
…last month’s special edition of In Plain English—COVID-19, the vaccines, and melanoma: What do melanoma patients and their families need…
,
Interview with Dr. Zeynep Eroglu, Medical Oncologist, Moffitt Cancer Center
…and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma. Dr. Eroglu is…
,
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag
…of melanoma has been increasing steadily for the last 30 years. In the United States, 106,110 new diagnoses of melanoma…
,
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026